You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition

Article metrics

Article menu

Download PDFPDF

Review
Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition

 

Online download statistics by month:

Online download statistics by month: January 2022 to August 2025

AbstractFullPdf
Jan 202225826352
Feb 2022327330139
Mar 202216517281
Apr 202215916764
May 202216417976
Jun 202213514080
Jul 202212412566
Aug 202214014157
Sep 202213113576
Oct 202213614073
Nov 2022838339
Dec 2022808038
Jan 2023707044
Feb 2023899047
Mar 2023636644
Apr 2023606027
May 2023484837
Jun 2023828224
Jul 2023616235
Aug 2023727230
Sep 2023575725
Oct 2023515139
Nov 2023596028
Dec 2023707135
Jan 2024474729
Feb 2024656727
Mar 2024868887
Apr 2024535545
May 2024697139
Jun 2024606040
Jul 2024717349
Aug 2024545335
Sep 2024727240
Oct 2024727234
Nov 2024484938
Dec 202411111451
Jan 2025444437
Feb 2025261261103
Mar 2025515242
Apr 2025939432
May 2025636539
Jun 2025646530
Jul 2025110
Aug 2025110
Total407041482053